We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Critical Path Initiative Will Boost Drug Safety, Woodcock Says
Critical Path Initiative Will Boost Drug Safety, Woodcock Says
May 4, 2005
The FDA’s Critical Path Initiative, which aims to bring more efficiency to the drug development process, is another agency program that will play a major role in addressing drug safety concerns, according to a top FDA official.